Nifty
Sensex
:
:
24334.55
77656.09
115.50 (0.48%)
286.98 (0.37%)

Pharmaceuticals & Drugs - Global

Rating :
74/99

BSE: 524742 | NSE: CAPLIPOINT

2471.80
25-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  2506.9
  •  2516.8
  •  2459.8
  •  2496.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  50538
  •  125591298
  •  2699
  •  1500.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 18,789.71
  • 28.24
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 18,169.24
  • 0.16%
  • 4.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.57%
  • 1.56%
  • 14.62%
  • FII
  • DII
  • Others
  • 5.75%
  • 2.06%
  • 5.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.29
  • 12.79
  • 9.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 25.99
  • 14.81
  • 7.99

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 27.90
  • 17.23
  • 12.54

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.94
  • 22.93
  • 26.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.59
  • 4.61
  • 5.13

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.31
  • 16.10
  • 18.65

Earnings Forecasts:

(Updated: 22-08-2026)
Description
2026
2027
2028
2029
Adj EPS
52
18
13.47
83.05
P/E Ratio
47.53
137.32
183.50
29.76
Revenue
27.06
23.74
-
2137.9
EBITDA
2488
2805.3
-
748.2
Net Income
860.4
981
-
628.4
ROA
712.75
816.7
-
21.65
P/B Ratio
1.35
1.46
-
5.57
ROE
4.38
3.98
-
19.81
FCFF
17.15
16.95
-
437.72
FCFF Yield
550.07
541.26
3360.18
2.39
Net Debt
3
2.95
18.33
1391.6
BVPS
1825.1
1695.6
-
443.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
610.36
510.22
19.63%
600.16
502.45
19.45%
542.77
492.96
10.10%
534.04
483.10
10.54%
Expenses
396.88
332.46
19.38%
395.92
334.39
18.40%
353.08
330.67
6.78%
344.87
318.34
8.33%
EBITDA
213.48
177.76
20.09%
204.24
168.06
21.53%
189.69
162.29
16.88%
189.17
164.76
14.82%
EBIDTM
34.98%
34.84%
34.03%
33.45%
34.95%
32.92%
35.42%
34.10%
Other Income
33.55
23.14
44.99%
28.36
25.74
10.18%
33.68
31.36
7.40%
30.37
20.77
46.22%
Interest
0.18
0.18
0.00%
0.36
0.17
111.76%
0.18
0.18
0.00%
0.16
0.21
-23.81%
Depreciation
21.62
16.29
32.72%
18.80
17.04
10.33%
19.28
16.20
19.01%
18.40
16.76
9.79%
PBT
225.23
184.43
22.12%
213.44
176.59
20.87%
203.91
177.27
15.03%
200.98
168.56
19.23%
Tax
46.13
33.70
36.88%
40.56
31.39
29.21%
38.03
37.19
2.26%
40.77
37.65
8.29%
PAT
179.10
150.73
18.82%
172.88
145.20
19.06%
165.88
140.08
18.42%
160.21
130.91
22.38%
PATM
29.34%
29.54%
28.81%
28.90%
30.56%
28.42%
30.00%
27.10%
EPS
23.28
20.11
15.76%
22.38
18.76
19.30%
21.56
18.28
17.94%
20.32
17.21
18.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
2,287.33
1,937.47
1,694.10
1,466.73
1,269.41
1,061.29
863.20
648.69
539.84
401.65
238.72
Net Sales Growth
15.01%
14.37%
15.50%
15.54%
19.61%
22.95%
33.07%
20.16%
34.41%
68.25%
 
Cost Of Goods Sold
915.64
770.84
724.18
663.21
557.51
471.74
413.16
288.78
238.18
184.93
121.16
Gross Profit
1,371.69
1,166.63
969.92
803.52
711.90
589.55
450.04
359.91
301.66
216.72
117.56
GP Margin
59.97%
60.21%
57.25%
54.78%
56.08%
55.55%
52.14%
55.48%
55.88%
53.96%
49.25%
Total Expenditure
1,490.75
1,290.54
1,142.66
1,026.21
874.88
737.04
603.13
416.84
344.52
276.84
174.51
Power & Fuel Cost
-
37.83
33.57
25.53
21.40
16.36
14.81
13.76
10.98
9.91
7.56
% Of Sales
-
1.95%
1.98%
1.74%
1.69%
1.54%
1.72%
2.12%
2.03%
2.47%
3.17%
Employee Cost
-
177.15
142.66
136.12
114.74
101.97
67.15
45.58
37.61
29.71
17.92
% Of Sales
-
9.14%
8.42%
9.28%
9.04%
9.61%
7.78%
7.03%
6.97%
7.40%
7.51%
Manufacturing Exp.
-
120.13
117.73
90.99
82.01
69.85
68.23
43.49
37.11
28.56
14.33
% Of Sales
-
6.20%
6.95%
6.20%
6.46%
6.58%
7.90%
6.70%
6.87%
7.11%
6.00%
General & Admin Exp.
-
112.05
92.97
85.38
66.68
49.52
29.69
23.02
14.62
13.73
8.15
% Of Sales
-
5.78%
5.49%
5.82%
5.25%
4.67%
3.44%
3.55%
2.71%
3.42%
3.41%
Selling & Distn. Exp.
-
62.25
24.88
18.78
27.52
18.03
9.95
2.08
5.92
9.41
2.29
% Of Sales
-
3.21%
1.47%
1.28%
2.17%
1.70%
1.15%
0.32%
1.10%
2.34%
0.96%
Miscellaneous Exp.
-
10.29
6.67
6.20
5.02
9.57
0.14
0.13
0.10
0.59
2.29
% Of Sales
-
0.53%
0.39%
0.42%
0.40%
0.90%
0.02%
0.02%
0.02%
0.15%
1.30%
EBITDA
796.58
646.93
551.44
440.52
394.53
324.25
260.07
231.85
195.32
124.81
64.21
EBITDA Margin
34.83%
33.39%
32.55%
30.03%
31.08%
30.55%
30.13%
35.74%
36.18%
31.07%
26.90%
Other Income
125.96
96.43
66.94
56.52
38.89
27.93
41.33
19.03
12.67
9.96
3.66
Interest
0.88
0.61
0.78
0.78
0.70
1.59
0.32
0.58
0.61
0.52
0.34
Depreciation
78.10
65.96
53.44
44.99
46.90
36.97
31.62
23.43
19.00
13.30
7.48
PBT
843.56
676.79
564.16
451.27
385.82
313.62
269.46
226.88
188.38
120.95
60.05
Tax
165.49
135.69
103.01
74.36
77.37
62.19
54.38
50.32
43.74
25.44
14.28
Tax Rate
19.62%
20.05%
18.26%
16.48%
20.05%
19.83%
20.18%
22.18%
23.22%
21.03%
23.78%
PAT
678.07
536.31
457.09
376.26
299.84
242.27
215.00
176.56
144.78
95.61
45.77
PAT before Minority Interest
665.36
541.09
461.42
376.99
308.45
251.43
215.08
176.56
144.63
95.50
45.77
Minority Interest
-12.71
-4.78
-4.33
-0.73
-8.61
-9.16
-0.08
0.00
0.15
0.11
0.00
PAT Margin
29.64%
27.68%
26.98%
25.65%
23.62%
22.83%
24.91%
27.22%
26.82%
23.80%
19.17%
PAT Growth
19.61%
17.33%
21.48%
25.49%
23.76%
12.68%
21.77%
21.95%
51.43%
108.89%
 
EPS
89.22
70.57
60.14
49.51
39.45
31.88
28.29
23.23
19.05
12.58
6.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,850.49
2,315.71
1,880.48
1,483.93
1,185.83
947.91
632.91
363.83
224.76
128.14
Share Capital
89.78
89.77
89.76
89.74
89.71
89.71
51.05
15.12
15.12
15.11
Total Reserves
2,741.06
2,211.72
1,775.35
1,378.74
1,081.33
848.76
575.01
345.42
209.56
111.40
Non-Current Liabilities
13.24
7.89
2.13
12.55
17.39
24.86
23.42
27.86
19.90
13.69
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.02
0.29
0.32
0.48
0.73
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.74
9.04
7.78
8.48
5.69
5.23
0.13
0.00
0.40
1.63
Current Liabilities
305.99
330.85
268.00
207.68
142.85
144.32
86.11
108.67
113.36
125.04
Trade Payables
217.58
229.62
152.56
155.94
88.50
64.14
60.47
94.23
78.60
55.71
Other Current Liabilities
64.28
90.29
99.94
48.68
51.87
79.28
24.20
13.86
33.09
60.39
Short Term Borrowings
0.55
0.28
3.41
0.50
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
23.58
10.66
12.09
2.56
2.48
0.91
1.44
0.58
1.67
8.94
Total Liabilities
3,205.62
2,685.57
2,177.40
1,730.11
1,363.61
1,125.75
742.52
500.45
358.38
267.14
Net Block
545.78
452.66
279.81
286.57
305.34
272.50
226.84
169.48
151.83
144.23
Gross Block
859.52
702.31
480.32
445.74
422.58
354.79
271.51
231.79
195.15
180.76
Accumulated Depreciation
313.74
249.65
200.51
159.17
117.24
82.29
44.67
62.31
43.31
36.53
Non Current Assets
1,071.67
792.65
625.21
432.29
349.04
303.23
248.83
196.34
179.16
148.61
Capital Work in Progress
143.50
116.62
220.71
17.73
13.88
20.12
9.70
15.29
3.42
0.23
Non Current Investment
279.13
137.63
70.52
37.01
0.66
0.56
0.33
0.33
13.24
0.44
Long Term Loans & Adv.
88.61
78.31
51.51
89.90
7.92
10.05
11.95
11.23
10.67
3.71
Other Non Current Assets
14.65
7.43
2.66
1.08
21.24
0.00
0.00
0.00
0.00
0.00
Current Assets
2,133.95
1,892.92
1,552.19
1,297.82
1,014.57
822.53
493.69
304.11
179.22
118.53
Current Investments
311.33
237.98
210.18
51.97
10.54
60.23
69.62
46.34
4.20
0.00
Inventories
336.10
363.04
288.22
227.31
179.01
238.23
37.45
28.46
22.29
18.81
Sundry Debtors
632.49
542.72
394.06
317.05
279.36
228.96
159.81
125.88
33.02
7.95
Cash & Bank
591.41
552.74
493.48
462.99
438.33
223.43
152.99
79.28
93.07
68.10
Other Current Assets
262.62
50.43
22.82
13.61
107.33
71.68
73.83
24.16
26.63
23.67
Short Term Loans & Adv.
185.51
146.01
143.43
224.89
87.08
56.81
64.61
17.28
19.31
12.58
Net Current Assets
1,827.96
1,562.07
1,284.19
1,090.14
871.72
678.21
407.58
195.44
65.86
-6.51
Total Assets
3,205.62
2,685.57
2,177.40
1,730.11
1,363.61
1,125.76
742.52
500.45
358.38
267.14

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
432.37
318.39
271.37
336.73
268.61
44.68
83.42
66.49
67.61
42.40
PBT
676.78
564.43
451.35
385.82
313.62
269.46
226.88
188.38
120.95
60.05
Adjustment
5.51
2.40
11.77
30.44
23.09
7.09
19.12
14.84
8.61
3.87
Changes in Working Capital
-122.28
-139.44
-103.75
1.96
-1.96
-177.11
-120.06
-100.38
-38.39
-5.13
Cash after chg. in Working capital
560.01
427.39
359.37
418.22
334.75
99.44
125.94
102.84
91.16
58.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-127.64
-109.00
-88.00
-81.49
-66.14
-54.76
-42.51
-36.35
-23.55
-16.38
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-334.73
-320.04
-217.58
-376.77
-29.44
-54.50
-100.46
-69.02
-36.11
-5.72
Net Fixed Assets
-55.85
-18.39
-56.57
-3.66
-35.46
-43.65
58.45
-48.43
-19.56
-7.66
Net Investments
-218.29
-99.00
-220.45
-115.52
46.59
-27.53
-120.03
-29.43
-17.35
0.01
Others
-60.59
-202.65
59.44
-257.59
-40.57
16.68
-38.88
8.84
0.80
1.93
Cash from Financing Activity
-38.32
-38.07
-28.17
-40.68
-23.98
79.77
89.79
-11.60
-6.74
-13.95
Net Cash Inflow / Outflow
59.32
-39.72
25.62
-80.72
215.19
69.94
72.76
-14.13
24.76
22.73
Opening Cash & Equivalents
138.70
177.56
150.76
231.57
220.77
150.65
77.17
91.31
66.55
45.37
Closing Cash & Equivalent
193.74
134.20
170.92
150.76
435.72
220.77
150.65
77.17
91.31
68.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
362.67
293.21
235.91
183.89
144.94
114.21
78.03
47.69
29.73
16.25
ROA
18.37%
18.98%
19.30%
19.94%
20.20%
23.02%
28.41%
33.68%
30.54%
18.46%
ROE
21.72%
22.97%
23.68%
24.77%
25.65%
29.58%
37.14%
49.43%
54.97%
43.13%
ROCE
26.22%
26.92%
26.85%
28.77%
28.82%
33.35%
45.59%
64.08%
69.03%
55.41%
Fixed Asset Turnover
2.48
2.87
3.17
2.92
2.73
2.76
2.58
2.53
2.14
1.48
Receivable days
110.70
100.92
88.48
85.74
87.41
82.19
80.37
53.72
18.62
10.40
Inventory Days
65.86
70.16
64.15
58.42
71.75
58.28
18.54
17.16
18.68
24.83
Payable days
105.88
96.31
84.89
80.02
59.05
28.33
65.76
89.68
88.17
103.48
Cash Conversion Cycle
70.68
74.76
67.73
64.14
100.11
112.15
33.15
-18.80
-50.88
-68.24
Total Debt/Equity
0.00
0.00
0.00
0.00
0.01
0.04
0.00
0.00
0.00
0.02
Interest Cover
1110.48
724.63
579.65
552.17
198.25
843.86
391.22
309.72
235.08
179.35

News Update:


  • USFDA completes inspection at Tamil Nadu facility of Caplin Point’s arm
    22nd Aug 2026, 11:11 AM

    At the end of the inspection, the company received Form 483 with 10 observations

    Read More
  • Caplin Point Labs. - Quarterly Results
    13th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.